Alloantigen-activated (AAA) CD4+ T cells reinvigorate host endogenous T cell immunity to eliminate pre-established tumors in mice
Abstract Background Cancer vaccines that induce endogenous antitumor immunity represent an ideal strategy to overcome intractable cancers. However, doing this against a pre-established cancer using autologous immune cells has proven to be challenging. “Allogeneic effects” refers to the induction of...
Main Authors: | Kazuhiro Mochizuki, Shogo Kobayashi, Nobuhisa Takahashi, Kotaro Sugimoto, Hideki Sano, Yoshihiro Ohara, Shin Mineishi, Yi Zhang, Atsushi Kikuta |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-021-02102-6 |
Similar Items
-
Immune-related genes in tumor-specific CD4+ and CD8+ T cells in colon cancer
by: Xi Yang, et al.
Published: (2020-06-01) -
Research progress on targetingmetabolic reprogramming of tumormicroenvironment to reinvigorate exhausted CD8+T cells
by: Zhong Jiaxin, et al.
Published: (2022-06-01) -
In vitro testing of immunosupressive effects of mesenchymal stromal cells on lymphocytes stimulated with alloantigens
by: Daniel Lysak, et al.
Published: (2015-06-01) -
VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens
by: Ibel Carri, et al.
Published: (2025-01-01) -
The origin of human CD20+ T cells: a stolen identity?
by: Marina Rode von Essen, et al.
Published: (2024-11-01)